20 September 2022

Dechra^® Pharmaceuticals PLC

(the Company)

2022 Annual Financial Report

The Company announced its Preliminary Results on 5 September 2022 in accordance with the financial reporting obligations of the Disclosure and Transparency Rules.

Copies of the Annual Financial Report for the year ended 30 June 2022, Notice of Annual General Meeting and Proxy Form have today been mailed to shareholders.

In accordance with Listing Rule 9.6.1 a copy of the Annual Financial Report and Notice of Meeting has been submitted to the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Annual Financial Report, Notice of Annual General Meeting and information relating to the voting rights of Shareholders (as required by section 311A of the Companies Act 2006) are available to view on the Company's website www.dechra.com.  

Further copies of the Annual Report are available from the Company's registered office at:

24 Cheshire Avenue

Cheshire Business Park

Lostock Gralam

Northwich

CW9 7UA

Enquiries:

Melanie Hall, Company Secretary

Dechra Pharmaceuticals PLC

Tel: +44 (0) 1606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. 

For more information please visit: www.dechra.com

LEI: 213800J4UVB5OWG8VX82

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.